Ftse Mib
35.410,13
0,12%
DAX
18.738,81
-0,72%
S&P 500
5.297,10
-0,21%
NASDAQ
16.698,32
-0,26%
Bitcoin
65.603,86
0,56%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Genuit Group Plc (GEN) Genuit Group Plc (GEN) Notizie

GEN

Genuit (GEN)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:GEN
DataOraFonteTitoloSimboloCompagnia
14/05/202409:00PR Newswire (US)Deepfakes, AI-Manipulated Audio, and Hijacked Social Media Surge in 2024LSE:GENGenuit Group Plc
02/05/202417:57RNS Regulatory NewsGenuit Group PLC Block listing Interim ReviewLSE:GENGenuit Group Plc
24/04/202411:39RNS Regulatory NewsGenuit Group PLC Notice of AGMLSE:GENGenuit Group Plc
10/04/202417:24RNS Regulatory NewsGenuit Group PLC Director/PDMR ShareholdingLSE:GENGenuit Group Plc
09/04/202417:28RNS Regulatory NewsGenuit Group PLC Director DeclarationLSE:GENGenuit Group Plc
12/03/202411:40Alliance NewsAlliance NewsGenuit revenue drops on lower divisional sales but profit surgesLSE:GENGenuit Group Plc
12/03/202408:09Alliance NewsAlliance News*Genuit says 2024 trading has started in line w/ expectations, despite market uncertaintyLSE:GENGenuit Group Plc
12/03/202408:09Alliance NewsAlliance News*Genuit declares total dividend per share of 12.4p vs 12.3p YoYLSE:GENGenuit Group Plc
12/03/202408:07Alliance NewsAlliance News*Genuit 2023 pretax profit GBP48.4m vs GBP45.4m YoYLSE:GENGenuit Group Plc
12/03/202408:00RNS Regulatory NewsGenuit Group PLC Final ResultsLSE:GENGenuit Group Plc
19/02/202410:00RNS Regulatory NewsGenuit Group PLC Notice of Results and Investor PresentationLSE:GENGenuit Group Plc
23/01/202416:49UK RegulatoryGenuit Group PLC Holding(s) in CompanyLSE:GENGenuit Group Plc
23/01/202412:24UK RegulatoryGenmab A/S Genmab Announces Net Sales Of Darzalex(R) (daratumumab) For 2023LSE:GENGenuit Group Plc
23/01/202400:40UK RegulatoryGenmab A/S Genmab Announces Decision In Arbitration Appeal Under License Agreement With JanssenLSE:GENGenuit Group Plc
09/01/202412:45UK RegulatoryGenmab A/S Tivdak(R) (tisotumab vedotin-tftv) Supplemental Biologics License Application Accepted For Priority Review By U.S. Food And Drug Administration For Patients With Recurrent Or Metastatic Cervical CancerLSE:GENGenuit Group Plc
03/01/202406:55UK RegulatoryGenmab A/S Transactions With Shares And Linked Securities In Genmab A/S Made By Managerial Employees And Their Closely Associated PersonsLSE:GENGenuit Group Plc
02/01/202415:52UK RegulatoryGenmab A/S Genmab To Present At The 42nd Annual J.P. Morgan Healthcare ConferenceLSE:GENGenuit Group Plc
12/12/202313:00UK RegulatoryGenmab A/S Genmab To Hold 2023 R&D Update And Ash Data Review MeetingLSE:GENGenuit Group Plc
09/12/202318:00UK RegulatoryGenmab A/S New Pivotal Data For Bispecific Antibody Epcoritamab (DuoBody(R) Cd3xcd20) Demonstrates High Overall And Complete Responses In Patients With Hard-To-Treat Relapsed/Refractory Follicular Lymphoma (FL)LSE:GENGenuit Group Plc
05/12/202323:26UK RegulatoryGenmab A/S Capital Increase In Genmab As A Result Of Employee Warrant ExerciseLSE:GENGenuit Group Plc
27/11/202313:00UK RegulatoryGenmab A/S Genmab Announces Positive Regulatory Updates For Epcoritamab (EPKINLY(R)/Tepkinly(R)) For The Treatment Of Relapsed/Refractory Follicular LymphomaLSE:GENGenuit Group Plc
22/11/202308:00UK RegulatoryGenuit Group PLC Strategy Progress Update NotificationLSE:GENGenuit Group Plc
21/11/202322:42UK RegulatoryGenmab A/S Grant Of Restricted Stock Units To Board Members And Employees And Grant Of Warrants To Employees In GenmabLSE:GENGenuit Group Plc
15/11/202310:03Alliance NewsAlliance NewsGenuit shares rise as annual profit predicted to exceed expectationsLSE:GENGenuit Group Plc
15/11/202308:00UK RegulatoryGenuit Group PLC Trading UpdateLSE:GENGenuit Group Plc
09/11/202315:14UK RegulatoryGenmab A/S Major Shareholder AnnouncementLSE:GENGenuit Group Plc
09/11/202311:00UK RegulatoryGenmab A/S Genmab To Present At Jefferies London Healthcare ConferenceLSE:GENGenuit Group Plc
07/11/202317:01UK RegulatoryGenmab A/S Genmab Announces Financial Results For The First Nine Months Of 2023LSE:GENGenuit Group Plc
02/11/202314:05UK RegulatoryGenmab A/S Genmab Announces Multiple Abstracts To Be Presented At The 65th Annual Meeting And Exposition Of The American Society Of Hematology (ASH)LSE:GENGenuit Group Plc
01/11/202311:58Alliance NewsAlliance NewsIN BRIEF: Genuit confirms interim CFO Tim Pullen as permanent CFOLSE:GENGenuit Group Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:GEN

La tua Cronologia

LSE
LFC
COIN
BASICUSD
BASIC Token
COIN
SIFUSD
COIN
BIXCGBP
LSE
OJ29
Citi Fun 25
EU
CD5
Amundi Euro Stoxx 50 Uci...
ASX
RDCN
Redcape Hotel
COIN
MROGBP
Mero Currency
LSE
XC53
Citi Fun 25
LSE
AFAA
BIT
UC74R4
Unicredit Bank
USOTC
AVACF
Avance Gas (PK)
USOTC
PNDFF
PT Indofood CBP Sukses M... (PK)
LSE
HR99
Citi Fun 25
COIN
REUR
EU
4687T
4687T
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network